HTR2C and migraine disorder: Although current evidence does not directly link the 5-HT2C receptor with migraines or the trigeminal vascular system, several clinical trials have reported migraines as a common adverse reaction (Smith et al., 2010; Fidler et al., 2011), suggesting a potential role for 5-HT2C in pharmacologically induced migraines.